Evidence map›Paper›PMID 31452467›Full record

ArticleParasitology2019

Promastigote secretory gel from natural and unnatural sand fly vectors exacerbate

E Giraud, M Svobodová, I Müller, P Volf, M E Rogers

Open access · hybridAbstract read
In one paragraph

Article in Parasitology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Insights intoVeterinary sciences · 2021
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

E GiraudFaculty of Infectious Tropical Diseases, Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.
M SvobodováDepartment of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic.
I MüllerFaculty of Medicine, Division of Infectious Diseases, Department of Medicine, Section of Immunology at St. Mary's, Imperial College London, London, UK.
P VolfDepartment of Parasitology, Faculty of Science, Charles University in Prague, Prague, Czech Republic.
M E RogersFaculty of Infectious Tropical Diseases, Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-6542-6438
Charles University · CZLondon School of Hygiene & Tropical Medicine · GBSt Mary's Hospital · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H022406/1Wellcome Trust GR078223MA
6 · The paper itself

Abstract

Leishmania rely heavily on glycans to complete their digenetic life cycle in both mammalian and phlebotomine sand fly hosts. Leishmania promastigotes secrete a proteophosphoglycan-rich gel (Promastigote Secretory Gel, PSG) that is regurgitated during transmission and can exacerbate infection in the skin. Here we explored the role of PSG from natural Leishmania-sand fly vector combinations by obtaining PSG from Leishmania (L.) major-infected Phlebotomus (P.) papatasi and P. duboscqi and L. tropica-infected P. arabicus. We found that, in addition to the vector's saliva, the PSG from L. major and L. tropica potently exacerbated cutaneous infection in BALB/c mice, improved the probability of developing a patent cutaneous lesion, parasite growth and the evolution of the lesion. Of note, the presence of PSG in the inoculum more than halved the prepatent period of cutaneous L. tropica infection from an average of 32 weeks to 13 weeks. In addition, L. major and L. tropica PSG extracted from the permissive experimental vector, Lutzomyia (Lu.) longipalpis, also exacerbated infections in mice. These results reinforce and extend the hypothesis that PSG is an important and evolutionarily conserved component of Leishmania infection that can be used to facilitate experimental infection for drug and vaccine screening.

Indexed as

AnimalsFemaleLeishmania majorLeishmaniasis, CutaneousLeishmania tropicaMembrane ProteinsMiceMice, Inbred BALB CParasite LoadPhlebotomusProteoglycansProtozoan ProteinsSalivaSkinSymptom Flare UpMembrane ProteinsPpg1 protein, LeishmaniaProteoglycansProtozoan ProteinsCutaneous leishmaniasisLeishmaniaLeishmania majorLeishmania mexicanaLeishmania tropicaPSGsand flytransmissionzoonoses

Identifiers

PMID31452467
PMCPMC6939171
OpenAlexW2970243300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.